16 Sep 2020 --- Biosciences company Brightseed has landed US$27 million in financing, bringing its total funding to US$52 million. The company will use the investment for the R&D and commercialization of clinically-proven, plant-based discoveries in the F&B, nutraceutical and supplement industries.
